Surface staining of C57BL/6 cells and CD45 knock-out cells with anti-CD45 antibodies [EM-05] (GTX80169) and anti-CD45 [ALI-4A2].
Surface staining of C57BL/6 cells and CD45 knock-out cells with anti-CD45 antibodies [EM-05] (GTX80169) and anti-CD45 [ALI-4A2].
CD45 antibody [EM-05] (PE)
GTX80169
Overview
- SupplierGeneTex
- Product NameCD45 antibody [EM-05] (PE) - KO/KD Validated
- Delivery Days Customer9
- Clone IDEM-05
- Concentration0.5 mg/ml
- FormulationLiquid
- Gene ID19264
- Target namePtprc
- Target descriptionprotein tyrosine phosphatase, receptor type, C
- Target synonymsB220; Cd45; CD45R; L-CA; leukocyte common antigen; loc; Ly-; Ly-5; lymphocyte antigen 5; lymphocyte common antigen; Lyt-; Lyt-4; receptor-type tyrosine-protein phosphatase C; T200
- Protein IDP06800
- Protein NameReceptor-type tyrosine-protein phosphatase C
- Storage Instruction2°C to 8°C
- UNSPSC12352203
References
- Liposomal TLR9 Agonist Combined with TLR2 Agonist-Fused Antigen Can Modulate Tumor Microenvironment through Dendritic Cells. Shen KY et al., 2020 Mar 28, Cancers (Basel)Read more
- Depletion of tumor-associated macrophages enhances the anti-tumor immunity induced by a Toll-like receptor agonist-conjugated peptide. Shen KY et al., 2014, Hum Vaccin ImmunotherRead more
- Toll-like receptor 9 agonist enhances anti-tumor immunity and inhibits tumor-associated immunosuppressive cells numbers in a mouse cervical cancer model following recombinant lipoprotein therapy. Chang LS et al., 2014 Mar 19, Mol CancerRead more